Poseida Therapeutics Inc
NASDAQ:PSTX 3:50:03 PM EDT
| Market Cap (Intraday) | 601.66M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $7.06 |
| 50-Day MA | $5.79 |
| 200-Day MA | $3.84 |
Poseida Therapeutics Inc Stock, NASDAQ:PSTX
9390 Towne Centre Drive, Suite 200, San Diego, California 92121
United States of America
Phone: +1.858.779.3100
Number of Employees: 263
Description
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.